Timely thrombolysis: Synergism to open arteries and reduce mortality rates

American Heart Journal

Volumn 137, Issue 1, 1999, Pages 1-3

  Cannon, C P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANISTREPLASE; FIBRINOLYTIC AGENT; RETEPLASE; STREPTOKINASE; UROKINASE;

DRUG EFFICACY; DRUG RESEARCH; DRUG SCREENING; EDITORIAL; FIBRINOLYTIC THERAPY; HEART INFARCTION; HUMAN; PRIORITY JOURNAL;

EID: 0032929165     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70452-7     Document Type: Editorial

References (23)

1. Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico GISSI Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction Lancet 1 1986 397 401
2. ISIS-2 Second International Study of Infarct Survival Collaborative Group Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2 Lancet 2 1988 349 360
3. E Braunwald Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival: Should the paradigm be expanded? Circulation 79 1989 441 444
4. CP Cannon EM Antman R Walls E Braunwald Time as an adjunctive agent to thrombolytic therapy J Thromb Thrombolysis 1 1994 27 34
5. National Heart Attack Alert Program Coordinating Committee: 60 Minutes to Treatment Working Group Emergency department: rapid identification and treatment of patients with acute myocardial infarction Ann Emerg Med 23 1994 311 329
6. E. Braunwald The open-artery theory is alive and well—again N Engl J Med 329 1993 1650 1652
7. CP Cannon E. Braunwald GUSTO, TIMI and the case for rapid reperfusion Acta Cardiol 49 1994 1 8
8. AM Lincoff EJ Topol RM Califf Significance of a coronary artery with Thrombolysis in Myocardial Infarction grade 2 flow “patency” (Outcome in the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Trials) Am J Cardiol 75 1995 871 876
9. The GUSTO Angiographic Investigators The comparative effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function and survival after acute myocardial infarction N Engl J Med 329 1993 1615 1622
10. A Vogt R von Essen U Tebbe W Feuerer K-F Appel K-L Neuhaus Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of four German multicenter studies J Am Coll Cardiol 21 1993 1391 1395
11. TIMI Study Group The Thrombolysis in Myocardial Infarction (TIMI) Trial; Phase I findings N Engl J Med 312 1985 932 936
12. The GUSTO Investigators An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction N Engl J Med 329 1993 673 682
13. CP Cannon CH McCabe DJ Diver Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial J Am Coll Cardiol 24 1994 1602 1610
14. LK Newby WR Rutsch RM Califf Time from symptom onset to treatment and outcomes after thrombolytic therapy J Am Coll Cardiol 27 1996 1646 1655
15. EJ Topol RM Califf KL Lee on behalf of the GUSTO Investigators More on the GUSTO trial. (letter) N Engl J Med 331 1994 277 278 Published errata appear in N Engl J Med 1994;331:687 and 1994;331:1323
16. CP Cannon M. Smith Advances in alliteration in acute myocardial infarction: from “time to treatment” to onset to opening” J Thromb Thrombolysis 6 1998 5 10
17. U Zeymer U Tebbe R von Essen W Haarmann K-L Neuhaus for the ALKK Study Group Influence of time-to-treatment on early infarct-related artery patency after different thrombolytic regimens Am Heart J 136 1998 34 38
18. JH Chesebro G Knatterud R Roberts Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase 1: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase Circulation 76 1987 142 154
19. PG Steg T Laperche J-L Golmard Efficacy of streptokinase, but not tissue- type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment J Am Coll Cardiol 31 1998 776 779
20. VJ Marder S Sherry Thrombolytic therapy: current status N Engl J Med 318 1988 1512 1520 1585-94
21. LATE Study Group Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction Lancet 342 1993 759 766
22. EMERAS Estudio Multicentrico Estreptoquinasa Republicas de America del Sur Collaborative Group Randomised trial of late thrombolysis in patients with suspected acute myocardia infarction Lancet 342 1993 767 772
23. C Bode RW Smalling G Berg Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction Circulation 94 1996 891 898